Znanstveni rad - Izvorni znanstveni rad
Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem
Biomedicines, 10 (2022), 11; 2892. https://doi.org/10.3390/biomedicines10112892


Citirajte ovaj rad

Sertić, Z., Lucijanić, M., Bašić Kinda, S., Serventi Seiwerth, R., Periša, V., Sertić, D. ... Duraković, N. (2022). Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem. Biomedicines, 10. (11). doi: 10.3390/biomedicines10112892

Sertić, Zrinka, et al. "Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem." Biomedicines, vol. 10, br. 11, 2022. https://doi.org/10.3390/biomedicines10112892

Sertić, Zrinka, Marko Lucijanić, Sandra Bašić Kinda, Ranka Serventi Seiwerth, Vlatka Periša, Dubravka Sertić, Božena Coha, et al. "Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem." Biomedicines 10, br. 11 (2022). https://doi.org/10.3390/biomedicines10112892

Sertić, Z., et al. (2022) 'Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem', Biomedicines, 10(11). doi: 10.3390/biomedicines10112892

Sertić Z, Lucijanić M, Bašić Kinda S, Serventi Seiwerth R, Periša V, Sertić D, i sur.. Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem. Biomedicines [Internet]. 11.11.2022. [pristupljeno 22.02.2024.];10(11). doi: 10.3390/biomedicines10112892

Z. Sertić, et al., "Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem", Biomedicines, vol. 10, br. 11, Studeni 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:275960. [Citirano: 22.02.2024.]